Dr. Thomas Patterson, chief of the Division of Infectious Disease, discusses the clinical trials of the promising antiviral drug for COVID-19, remdesivir, in a video featured in this report.
Dr. Thomas Patterson, chief of the Division of Infectious Disease, discusses the clinical trials of the promising antiviral drug for COVID-19, remdesivir, in a video featured in this report.